Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Medicinal Chemicals & Botanical Products

Cronos Group Inc. to acquire CanAdelaar

Announced Dec 9, 2025 · Closed Oct 15, 2026 · Private target

Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed

Transaction

Acquirer
Cronos Group Inc. (CRON)
Target
CanAdelaar
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Oct 15, 2026

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Not disclosed
To the target
Not disclosed

Classification

Sector
Healthcare
Buyer's industry
Medicinal Chemicals & Botanical Products
Sources
  • 8-K (EX-99.1) · Oct 15, 2026

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.